Ann: Phase 2 Stroke Clinical Trial Update, page-16

I expect the trial to complete the dosing of all 92 patients many months before the recruitment target of the end of calendar year 2025.

In round figures to date there's been 20 patients dosed in 4 months in 5 hospitals. (Being overly generous here, there hasn't been all 5 hospitals dosing for the full 4 months) But to keep it simple let's just say 5 patients dosed per month.

Extrapolating, with all 10 hospitals recruiting = 10 patients per month. (Again, super conservative imo).

We require another ~70 patients enrolled to complete the trial, so +7 months @ 10 patients per month brings us to around end of February early March 2025.


Very obviously not an exact science and there's all sorts of variables at play, including how long the new hospitals sites take to start recruiting, but people claiming delays in the trial etc did not read the latest announcement stating the trial is in fact ahead of schedule.